At this time, posts about ABL Bio are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 85,000 shares of ABL Bio, while institutions have bought a net 14,000 shares, according to provisional data. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.


As of 11:31 AM on the 14th, ABL Bio's stock price is 34,900 KRW, down 2.65% from the previous day, with a trading volume of 4,348,101 shares, which is 227.8% of the 5-day average trading volume.


In addition to ABL Bio, posts by investors are also surging for Ssangyong Motor (003620), Hanwha Investment & Securities Preferred (003535), and Dongkuk S&C (100130).



※Source: AI Investment Assistant AI Rassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing